App-Quantinova.ai

THE ANTI-PLATELET EFFECT OF DIFFERENT LOADING DOSE OF TICAGRELOR IN PATIENTS WITH NON-ST ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY

Liu Huiliang - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ticagrelor

EVALUATION OF LEFT ATRIAL MORPHOLOGY BY A NOVEL VOLUME RENDERED IMAGING BASED ON THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY

Qing Zhou - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

LEFT VENTRICULAR ASSIST DEVICE EVALUATION USING CARDIAC CT: TWO-YEAR EXPERIENCE AT A HIGH-VOLUME CENTER

William Guy Weigolda - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

IMPACT OF INFERIOR VENA CAVA FILTER PLACEMENT ON OUTCOMES OF PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE AND CONTRAINDICATIONS TO ANTICOAGULATION: A PROPENSITY ANALYSIS

Tyson Turner - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

RECURRENT VENOUS THROMBOEMBOLISM IN PULMONARY EMBOLISM PATIENTS WITH RIGHT VENTRICULAR DYSFUNCTION IN THE HOKUSAI-VTE STUDY

Marjolein Brekelmans - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Edoxaban

COMPARISON OF RIVAROXABAN OR WARFARIN USE FOR VENOUS THROMBOEMBOLISM ON INPATIENT LENGTH OF STAY

Steven Deitelzweig - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

HOSPITALIZATION FOR PULMONARY EMBOLISM ASSOCIATED WITH ANTECEDENT TESTOSTERONE OR ESTROGEN THERAPY IN PATIENTS FOUND TO HAVE FAMILIAL THROMBOPHILIA

Matan Rothschild - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

FVIII

LONG-TERM (7-YEAR) CLINICAL OUTCOMES AFTER BIODEGRADABLE POLYMER-BASED BIOMATRIX BIOLIMUS-ELUTING STENT IMPLANTATION

Masanobu Ohya - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Umirolimus

INSIGHTS INTO THE ROLE OF PLATELETS IN FIBRIN CLOT FORMATION AND THE EFFICACY OF ANTI-PLATELET THERAPIES

Rebecca Knowlesa - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Ticagrelor

EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL

Sameer Bansilal - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Ticagrelor

FEASIBILITY OF DIRECT AORTIC IMPLANTATION OF THE LOTUS VALVE: A MULTICENTER EXPERIENCE

Vinayak Nilkanth Bapat - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

EFFICACY OF ANTICOAGULATION IN PREVENTING THROMBOEMBOLISM AFTER BIO PROSTHETIC AORTIC VALVE REPLACEMENT: A META-ANALYSIS

Abhilash Akinapelli - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

SAME-TT2R2 PREDICTS QUALITY OF ANTICOAGULATION IN PATIENTS WITH VENOUS THROMBOEMBOLISM: THE MAQI2 EXPERIENCE

Akash Kataruka - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

Theodore Leea - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Enoxaparin

RIVAROXABAN COMPARED TO LOW MOLECULAR WEIGHT HEPARIN IN TREATMENT OF MALIGNANCY ASSOCIATED VENOUS THROMBOEMBOLISM

Robert D. McBane - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH INSULIN TREATED DIABETES MELLITUS: INSIGHTS FROM THE TUXEDO TRIAL

Upendra Kaul - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

LATE CLINICAL OUTCOMES AFTER BIORESORBABLE OR PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: 2-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL

Dean J. Kereiakes - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Promus Element

EFFECTIVENESS OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN THE UNITED STATES

Eric Alexander Secemsky - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

MYOCARDIAL INFARCTION AFTER LATE DISCONTINUATION OF THIENOPYRIDINE THERAPY IN THE RANDOMIZED DAPT STUDY

Ada Stefanescua - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

OUTCOMES OF THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD IN VERY SMALL AND NOT VERY SMALL CORONARY ARTERIES: THE ABSORB III RANDOMIZED TRIAL

Gregg W. Stone - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Filters

7277 Abstracts